HOME >> BIOLOGY >> NEWS
16 outstanding researchers receive Singapore's highest honor in science and technology

en involved in countless discussions at research institutes and university departments, and in giving scientific talks and public lectures. These public lectures were always interesting, peppered with characteristic wit and humour, and delivered on key points. He spoke to the public and students in a way that they could understand, thereby helping to elevate the level of science consciousness and interest in Singapore.

Today, Singapore is internationally recognised as a growing biomedical research hub. Dr Brenner's ideas and influence on policies and initiatives have left a deep imprint in enhancing Singapore's capability and reputation in contemporary and leading edge biomedical science research.

For his distinguished and strategic contributions to the development of Singapore's scientific capability and culture, particularly in the biomedical sciences sector, Dr Sydney Brenner is awarded the National Science and Technology Medal 2006.

National Science Award 2006

Dr. Ruan Yijun

Dr. Wei Chia Lin

Dr. Patrick Ng

Dr. Sung Wing Kin

Genome Institute of Singapore

"For their innovative work in developing the Paired End diTag sequencing technology for comprehensive characterisation of the human genome and transcriptome"

The human genome sequence, which was completed in 2004, provides a framework of the entire genetic information in Homo sapiens. However the vast functional content within the genome is not well-defined. In order to fully understand human genetics, it is necessary to identify all the functional elements and analyze how these elements interact with each other to deliver biological outcomes.

The research focus of the Genome Technology and Biology group at Genome Institute of Singapore, led by Dr. Ruan Yijun and Dr. Wei Chia Lin, is to elucidate the structure of all functional DNA elements in the human genome with a focus on transcriptome characterization and transcr
'"/>

Contact: Ng Koon Ling
ng_koon_ling@a-star.edu.sg
656-826-6338
Agency for Science, Technology and Research (A*STAR), Singapore
11-Oct-2006


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology news :

1. AIBS honors outstanding contributions to the biological sciences
2. Lennart Nilsson Award for outstanding photography of the world of insects
3. Two at Yale named outstanding new environmental scientists by NIEHS
4. SNM honors outstanding contributors
5. American Physical Society honors outstanding achievements of two Brandeis scientists
6. Institute of Medicine: IOM Honors members for outstanding service
7. Society of Nuclear Medicine Technologist Section names Jan Winn as outstanding educator
8. Merck / AAAS announce 2005 winners for outstanding undergraduate research programs
9. Innovative tagging technique may help researchers better protect fish stocks
10. Penn researchers discover how key protein stops inflammation
11. ASU researchers partner with UOP to make biofuel for military jets a reality

Post Your Comments:
(Date:6/16/2015)... , June 16, 2015 /CNW Telbec/ - handyem ... centralized around the incorporation of handyem,s HPC-150 portable ... laboratory, the Mo-POD™. This unprecedented model of mobile ... Conference at the Pennsylvania ... June 15 th to 18 th ...
(Date:6/16/2015)... , June 16, 2015 Fingerprint Cards ... fingerprint sensors in the company,s portfolio from one of its ... planned to mainly take place during the third quarter 2015. ... Asia . Jörgen Lantto, CEO of ...   the   growing interest from smartphone OEMs in integrating ...
(Date:6/15/2015)... June 16, 2015 According to ... by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, ... 2020" published by MarketsandMarkets, The Natural Language Processing Market ... CAGR of 18.4% for the forecast period 2015-2020. ... 46 F igures spread   through 155 P ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5
(Date:7/2/2015)... ... July 02, 2015 , ... In’Tech ... surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, Inc ... provider of surgical instruments to the Spine Industry. The acquisition of Turner Medical ...
(Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan ... lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup ... prizes of US$15,000 and a period of expert mentorship from a senior industry figure ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: